Olivier RASCOL
Olivier RASCOL
UT3 Professor, CHU Purpan, Tonic (INSERM-UT3), CIC 1436 (INSERM-CHU-UT3), TMBI (Univ. Toulouse)
Verified email at univ-tlse3.fr
Title
Cited by
Cited by
Year
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results
CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ...
Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008
31102008
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
O Rascol, DJ Brooks, AD Korczyn, PP De Deyn, CE Clarke, AE Lang
New England Journal of Medicine 342 (20), 1484-1491, 2000
17712000
Association between early-onset Parkinson's disease and mutations in the parkin gene
CB Lücking, A Dürr, V Bonifati, J Vaughan, G De Michele, T Gasser, ...
New England Journal of Medicine 342 (21), 1560-1567, 2000
16322000
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on …
CG Goetz, W Poewe, O Rascol, C Sampaio, GT Stebbins, C Counsell, ...
Movement disorders 19 (9), 1020-1028, 2004
15752004
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): process, format, and clinimetric testing plan
CG Goetz, S Fahn, P Martinez‐Martin, W Poewe, C Sampaio, GT Stebbins, ...
Movement disorders 22 (1), 41-47, 2007
9362007
Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL‐PET study
AL Whone, RL Watts, AJ Stoessl, M Davis, S Reske, C Nahmias, AE Lang, ...
Annals of neurology 54 (1), 93-101, 2003
9262003
A double-blind, delayed-start trial of rasagiline in Parkinson's disease
CW Olanow, O Rascol, R Hauser, PD Feigin, J Jankovic, A Lang, ...
New England Journal of Medicine 361 (13), 1268-1278, 2009
8682009
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
K Seppi, D Weintraub, M Coelho, S Perez‐Lloret, SH Fox, ...
Movement Disorders 26 (S3), S42-S80, 2011
8532011
The unified Parkinson's disease rating scale (UPDRS): status and recommendations
Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease
Movement Disorders 18 (7), 738-750, 2003
7542003
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily …
O Rascol, DJ Brooks, E Melamed, W Oertel, W Poewe, F Stocchi, ...
The lancet 365 (9463), 947-954, 2005
6572005
Depression rating scales in Parkinson's disease: critique and recommendations
A Schrag, P Barone, RG Brown, AFG Leentjens, WM McDonald, ...
Movement disorders 22 (8), 1077-1092, 2007
6182007
Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study
U Sabatini, K Boulanouar, N Fabre, F Martin, C Carel, C Colonnese, ...
Brain 123 (2), 394-403, 2000
6182000
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
SH Fox, R Katzenschlager, SY Lim, B Ravina, K Seppi, M Coelho, ...
Movement Disorders 26 (S3), S2-S41, 2011
6002011
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
P Barone, W Poewe, S Albrecht, C Debieuvre, D Massey, O Rascol, ...
The Lancet Neurology 9 (6), 573-580, 2010
4982010
Evidence‐based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004
CG Goetz, W Poewe, O Rascol, C Sampaio
Movement disorders: official journal of the Movement Disorder Society 20 (5 …, 2005
4462005
Levodopa in the treatment of Parkinson's disease: current controversies
CW Olanow, Y Agid, Y Mizuno, A Albanese, U Bonucelli, P Damier, ...
Movement disorders 19 (9), 997-1005, 2004
4352004
Priorities in Parkinson's disease research
WG Meissner, M Frasier, T Gasser, CG Goetz, A Lozano, P Piccini, ...
Nature reviews Drug discovery 10 (5), 377-393, 2011
4262011
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder …
M Horstink, E Tolosa, U Bonuccelli, G Deuschl, A Friedman, P Kanovsky, ...
European journal of neurology 13 (11), 1186-1202, 2006
4142006
Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke
J Pariente, I Loubinoux, C Carel, JF Albucher, A Leger, C Manelfe, ...
Annals of neurology 50 (6), 718-729, 2001
4142001
Development and validation of the unified multiple system atrophy rating scale (UMSARS)
GK Wenning, F Tison, K Seppi, C Sampaio, A Diem, F Yekhlef, I Ghorayeb, ...
Movement Disorders 19 (12), 1391-1402, 2004
4122004
The system can't perform the operation now. Try again later.
Articles 1–20